COMMUNIQUÉS West-GlobeNewswire

Trim RX GLP-1 Weight Loss Medication Claims Evaluated: Investigating the TrimRX Treatment Options
20/03/2026
An informational report based on materials provided by MetaFit Pharma Solutions LLC detailing how the TrimRx telehealth platform presents its GLP-1 medication options, compounded and FDA-approved formulations, pricing [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20/03/2026
PALO ALTO, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today [...]
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026
20/03/2026
Real-World LEQEMBI Data Shows Patients Choose to Stay on Long-Term Treatment TOKYO and CAMBRIDGE, Mass., March 20, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc [...]
SafeSpace Global Corporation Reports Q2 Fiscal 2026 Financial Results; Company Transitions from Pre-Revenue to Revenue-Generating Stage, Expands Footprint with Nashville Office, and Initiates Steps Toward National Exchange Uplisting
20/03/2026
KNOXVILLE, TN., March 20, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC) (SafeSpace Global or the Company), a leader in multimodal AI-powered safety and security solutions company dedicated to [...]
Disclosure of a transparency notification from Aberdeen Group plc
20/03/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2026 – 6 PM CET Disclosure of a transparency notification from Aberdeen Group plc Pursuant to the Belgian act of 2 May 2007 on the [...]
Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
20/03/2026
EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
20/03/2026
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 20 March 2026 at 15.40 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual Meeting
20/03/2026
WAYNE, Pa., March 20, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Longeviti Neuro Solutions Appoints T. Rowe Price CEO Robert W. Sharps to Board of Directors
20/03/2026
--Veteran global investment leader joins neurotechnology company advancing AI-enabled brain health platforms-- BALTIMORE, March 20, 2026 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions , a neurotechnology company [...]
BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT
20/03/2026
Financing strengthens balance sheet and supports advancement of key development initiatives NEWTON, MA, March 20, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTC: BIXT), a clinical-stage biotechnology company focused on [...]
GUERBET : Mise à disposition du Document d’enregistrement universel 2025
20/03/2026
Mise à disposition du Document d’enregistrement universel 2025 Villepinte, le 20 mars 2026, Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, a déposé son [...]
Picard Medical / SynCardia to Present its Next-Generation Emperor Total Artificial Heart Technology at the American College of Cardiology’s Annual Scientific Session
20/03/2026
Poster presentation and conference exhibit will feature early preclinical data on the Company’s fully implantable, autoregulating artificial heart platform TUCSON, Ariz., March 20, 2026 (GLOBE NEWSWIRE) -- Picard [...]
Scientist Challenges CERN and Industry to Public ‘Known Dataset Test’ to Prove 3D-Flow Can Save Billions and Millions of Lives
20/03/2026
Crosetto Foundation calls for transparency at the 2026 Total Body PET Conference to evaluate technology capable of detecting early-stage cancer currently missed by existing systems DALLAS, March 20, 2026 (GLOBE NEWSWIRE [...]
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
20/03/2026
NASHVILLE, Tenn., March 20, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report fourth quarter 2025 financial results after the market closes on [...]
REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD
20/03/2026
Lausanne, Switzerland and Copenhagen, Denmark, March 20, 2026 (GLOBE NEWSWIRE) -- REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD Biopharma executive with more than 35 years of leadership across C-suite and [...]
CapsoVision Announces $14 Million Private Placement Financing
20/03/2026
Reports Preliminary, Unaudited Fourth-Quarter and Full Year 2025 Financial Results SARATOGA, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (the “Company”) (NASDAQ: CV), a commercial-stage medical [...]
RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET
20/03/2026
MOUNTAIN VIEW, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing [...]
Foundation Consumer Healthcare Sells Portion of Consumer Health Business
20/03/2026
Company Will Retain Flagship Brand, Plan B One-Step® PITTSBURGH, March 20, 2026 (GLOBE NEWSWIRE) -- Foundation Consumer Healthcare (FCH) announced today that it has entered into a definitive agreement to sell a portion [...]
WallabyPhenox Announces First U.S. Patient Treated with p48 & p64 MW HPC Flow Modulation Devices in PIANO IDE Trial
20/03/2026
IRVINE, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- WallabyPhenox today announced the successful treatment of the first U.S. patient in the p 48 and p64 MW HPC i n An eurysm O cclusion (PIANO) IDE trial, evaluating the [...]

Pages